Health Care & Hospital Law,
Civil Litigation
May 4, 2021
Objections predominate in opioid trial of 4 pharmaceutical companies
Attorneys for the other drug companies facing deceptive marketing allegations in California have repeatedly stressed the need for plaintiffs’ attorneys to clearly identify each individual drug company in allegations and questions asked of witnesses.
The goal of a 20-year-old pharmaceutical marketing campaign was to increase prescriptions and drive sales of opioids, a marketing executive testified in a deposition tape played Monday in California's $50 billion bench trial of four drugmakers accused of deceptive marketing.
In the third week of the state's case, Rhode Island attorney Fidelma L. Fitzpatrick of Motely Rice LLC played the 2019 testimony of Nathalie Leitch, a senior m...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
Enewsletter Sign-up
Related Content
Civil Litigation
Defense stymies expert testimony and materials in opioid trial
By Blaise Scemama
Civil Litigation
State expert’s data questioned by defense in Orange County opioid trial
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Expert says California in midst of opioid crisis
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Opioid makers hyped products while downplaying risks, expert testifies
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Quarter of patients addicted after opioid pain prescription, doctor testifies
By Blaise Scemama
Civil Litigation
Pharmaceutical CEO’s deposition played in opioid trial
By Blaise Scemama
Health Care & Hospital Law
Drug company lawyers grill historian in opioid trial
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Opioid makers argue for separate consideration in trial
By Blaise Scemama
